The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Amino-6-bromo-4-(2-(4-chlorophenyl)-2-oxoethyl)-8-methoxy-4H-chromene-3-carbonitrile ID: ALA4294978
PubChem CID: 145993624
Max Phase: Preclinical
Molecular Formula: C19H14BrClN2O3
Molecular Weight: 433.69
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(Br)cc2c1OC(N)=C(C#N)C2CC(=O)c1ccc(Cl)cc1
Standard InChI: InChI=1S/C19H14BrClN2O3/c1-25-17-7-11(20)6-14-13(15(9-22)19(23)26-18(14)17)8-16(24)10-2-4-12(21)5-3-10/h2-7,13H,8,23H2,1H3
Standard InChI Key: LJIONYINPMKNCE-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
29.6467 -5.0664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6456 -5.8936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3604 -6.3065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3586 -4.6536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0740 -5.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0773 -5.8911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7925 -6.3002 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.5089 -5.8853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5055 -5.0569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7858 -4.6433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2244 -6.2958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.7812 -3.8183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0645 -3.4098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0599 -2.5848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3524 -3.8262 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.7727 -2.1706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7685 -1.3464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0512 -0.9370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3368 -1.3579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3445 -2.1806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2192 -4.6397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9311 -4.2205 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.3610 -7.1315 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.6467 -7.5444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9322 -4.6540 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
31.0457 -0.1121 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
8 11 1 0
10 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 14 1 0
9 21 1 0
21 22 3 0
3 23 1 0
23 24 1 0
1 25 1 0
18 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 433.69Molecular Weight (Monoisotopic): 431.9876AlogP: 4.55#Rotatable Bonds: 4Polar Surface Area: 85.34Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.45CX LogP: 3.99CX LogD: 3.99Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.71Np Likeness Score: -0.71
References 1. Pontes O, Costa M, Santos F, Sampaio-Marques B, Dias T, Ludovico P, Baltazar F, Proença F.. (2018) Exploitation of new chalcones and 4H-chromenes as agents for cancer treatment., 157 [PMID:30081238 ] [10.1016/j.ejmech.2018.07.058 ]